• Inviragen Inc., of Fort Collins, Colo., said it started the second stage of its ongoing Phase II study testing DENVax, its dengue vaccine, following review and recommendation by the data safety monitoring board.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter